Abstract
Objective: Chronic illnesses are associated with reports of symptoms, problems, and dysfunction along multiple dimensions. To determine if the dimensionality is disease-specific and whether physical and emotional symptoms are concomitant and inseparable aspects of the illness experience, we present a factor analysis of symptom and problem reports from five different chronic conditions. Method: People with five different conditions participated in this study: multiple sclerosis (MS) (n=263), non-insulin-dependent diabetes mellitus (n=420), nonhead nonneck injury trauma (n=852), and a group of terminal patients comprised of acquired immune deficiency syndrome (AIDS) (n=99) and cancer (n=74) patients. Participants were asked to complete the Quality of Well-Being Scale (QWB) and symptom items from the QWB were factor analyzed. Results: Both within each condition and across conditions, two factors accounted for the majority of the explained variance and could be described as an Observable Limitations factor and a Subjective Symptoms factor. Conclusions: Our factor analyses suggest that physical and emotional symptoms covary and are common to different types of illness.
Similar content being viewed by others
References
World Health Organization:The World Health Organization Constitution. Geneva, Switzerland: 1947.
Ware JE, Gandek M, Kosinski M, et al: The factor structure and factor content of the SF-36 health status scales in seven countries: Results from the IQOLA project.Quality of Life Research. 1995,4:501–502.
Wells KB, Rogers W, Burnam A, Greenfield S, Ware JE: How the medical comorbidity of depressed patients differs across health care settings: Results from the Medical Outcomes Study.American Journal of Psychiatry. 1991,148:1688–1696.
Friedman HS, Booth-Kewley S: The “disease-prone personality.” A meta-analytic view of the construct.American Psychologist. 1987,42:539–555.
Davidson JR, Kudler HS, Saunders WB, Smith RD: Symptom and comorbidity patterns in WWII and Vietnam veterans with PTSD.Comprehensive Psychiatry. 1990,31:162–170.
Davidson JR, Kudler HS, Smith R, et al: Treatment of PTSD with amitriptyline and placebo.Archives of General Psychiatry. 1990,47:259–266.
Davidson JR, Kudler HS, Saunders WB, et al: Predicting response to amitryptyline in PTSD.American Journal of Psychiatry. 1993,150:1024–1029.
Golding JM, Burnam MA, Benjamin B, Wells KB: Risk factors for secondary depression in Mexican Americans and non-Hispanic Whites. Alcohol use, alcohol dependence, and reasons for drinking.Journal of Nervous and Mental Disease. 1993,181:166–175.
Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K: Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses.Archives of General Psychiatry. 1995,52:11–19.
Wells KB, Rogers W, Burnam A, Camp P: Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes.American Journal of Psychiatry. 1993,150:632–638.
Ware JE, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): Conceptual framework and items selection.Medical Care. 1992,30:473–483.
Sturm R, Wells KB: How can care for depression become more cost-effective?Journal of the American Medical Association. 1995,27:51–58.
Kaplan RM, Bush JW, Berry CC: Health status: Types of validity and the Index of Well-Being.Health Services Research. 1976,11:478–507.
Wilson JD, Braunwald E, Isselbacher KJ, et al (eds):Harrison's Principles of Internal Medicine. (12th Ed.). New York: McGraw-Hill Book Co., 1991.
Merck Manual of Diagnosis and Therapy (8th Ed.). Rahway, NJ: Merck Sharp & Dohme Research Laboratories, 1972.
Anderson JP, Bush JW, Berry CC: Internal consistency analysis: A method for studying the accuracy of function assessment for health outcome and quality of life evaluation.Journal of Clinical Epidemiology. 1988,41:127–137.
Kaplan RM, Atkins CJ, Timms R: Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease.Journal of Chronic Diseases. 1984,37:85–95.
Kaplan RM, Anderson JP, Patterson TL, et al: Validity of the Quality of Well-Being Scale for persons with HIV infection.Psychosomatic Medicine. 1995,57:138–147.
Squier HC, Ries AL, Kaplan RM, et al: Quality of well-being predicts survival in lung transplantation candidates.American Journal of Respiratory and Critical Care Medicine. 1995,152:2032–2036.
Bombardier C, Ware J, Russell IJ, et al: Auranofin therapy and quality of life in patients with rheumatoid arthritis.American Journal of Medicine. 1986,81:565–578.
Schwartz CE, Vollmer T, Lee H, and the North American Research Consortium on MS: New self-reported outcome measures for MS clinical research: The Symptom Inventory and the Performance Scales.Neurology. 1999,52:63–70.
Kaplan RM, Sieber WJ, Ganiats TG: The Quality of Well-Being Scale: Comparison of the interviewer-administered version with the self-administered questionnaire.Psychology and Health. 1997,12: 783–791.
Sieber WJ, Ganiats TG, Kaplan RM: Validation of a self-administered Quality of Well-Being Scale.Medical Outcomes Trust Bulletin. 1997,5:2–4.
Lord FM, Novick MR:Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley Publishing Co., 1968.
SPSS Reference Guide. Chicago: SPSS, Inc., 1990.
SAS/STAT User's Guide Version 6 (4th Ed.). Cary, NC: SAS Institute, Inc., 1990.
Cunningham AJ: Pies, levels, and languages: Why the contribution of mind to health and disease has been underestimated.Advances. 1995,11:4–11.
Leventhal EA, Hansell S, Diefenbach M, Leventhal H, Glass DC: Negative affect and self-report of physical symptoms: Two longitudinal studies of older adults.Health Psychology. 1996,15:193–199.
Robinson I: Personal narratives, social careers, and medical course: Analyzing life trajectories in autobiographies of people with multiple sclerosis.Social Science and Medicine. 1990,30:1173–1186.
Connelly JE, Smith GR, Philbrick JT, Kaiser DL: Healthy patients who perceive poor health and their use of primary care services.Journal of General Internal Medicine. 1991,6:47–51.
Schwartz CE, Fox B: Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis.Social Science and Medicine. 1995,40(3):359–370.
Gold MR, Siegel JE, Russell LB, Weinstein MC (eds):Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Lee TT, Solomon NA, Heidenreich PA, Oehlert J, Garber AM: Cost-effectiveness of screening for carotid stenosis in asymptomatic persons.Annals of Internal Medicine. 1997,126(5):336–346.
Siegel C, Laska E, Meisner M: Statistical methods for cost-effectiveness analyses.Controlled Clinical Trials. 1996,17(5):387–406.
Siegel JE, Weinstein MC, Russell LB, Gold MR: Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine.Journal of the American Medical Association. 1996,276(16):1339–1341.
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the Panel on Cost-Effectiveness in Health and Medicine.Journal of the American Medical Association. 1996,276(15):1253–1258.
Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC: The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.Journal of the American Medical Association. 1996,276(14):1172–1177.
Author information
Authors and Affiliations
Additional information
Preparation of this manuscript was supported in part by grants from the Agency for Health Care Policy & Research (1 RO1 HSO8582-01A1) and from Berlex Laboratories to Dr. Carolyn Schwartz; by grants from the Agency for Health Care Policy & Research (R18 HSO5617 and R1806912) to Dr. Larry Schneiderman, M.D., and an American Cancer Society Scholars Grant to Robert Kaplan, Ph.D.
About this article
Cite this article
Schwartz, C.E., Kaplan, R.M., Anderson, J.P. et al. Covariation of physical and mental symptoms across illnesses: Results of a factor analytic study. ann. behav. med. 21, 122–127 (1999). https://doi.org/10.1007/BF02908292
Issue Date:
DOI: https://doi.org/10.1007/BF02908292